April 17, 2017
Hyline makes key changes in R&D team
These changes are part of the company's continual investment in research and development to identify future market trends and to proactively implement procedures within the breeding programme to meet and exceed these constantly changing market requirements.
Dr. Neil O'Sullivan began the role of director of global product management on January 1. In this strategic role, Dr. O'Sullivan liaises with Hy-Line International's production centres to ensure genetic integrity is maintained at all times. He has been with Hy-Line since 1991, and was previously Hy-Line's director of research and development.
"Neil's role is external and customer focused. It requires detailed knowledge of our research programme and the progress that is being made in all lines, as well as management and knowledge-sharing practices on GP, PS and commercial layer varieties," said Jonathan Cade, president of Hy-Line International. "This transfer of know-how must be effectively communicated to our global distribution partners and, most importantly, to the commercial layer customers."
Dr. Danny Lubritz began his role as Hy-Line International's director of research and development on January 1. He has more than 18 years of experience in quantitative genetics and was previously the senior geneticist for Cobb-Vantress. He will lead the Research & Development programme, as well as the research team and research farm operations at Dallas Center, Iowa, US.